Disciplined Investments, LLC Biogen Inc. Transaction History

Disciplined Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$275.25 - $318.06 $825 - $954	-3 Reduced 1.01%	295 $84,000
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $58,752 - $66,945	229 Added 331.88%	298 $82,000
Q4 2022 Feb 01, 2023	SELL	$252.44 - $306.72 $56,799 - $69,012	-225 Reduced 76.53%	69 $19,000
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $187 - $223	1 Added 0.34%	294 $60,000
Q1 2022 Apr 22, 2022	BUY	$193.77 - $244.14 $3,100 - $3,906	16 Added 5.78%	293 $62,000
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $55,878 - $65,464	230 Added 489.36%	277 $77,000
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $60,897 - $70,313	-230 Reduced 83.03%	47 $13,000
Q1 2020 May 19, 2020	SELL	$268.85 - $341.04 $2,419 - $3,069	-9 Reduced 3.15%	277 $88,000
Q4 2019 May 19, 2020	BUY	$220.06 - $304.07 $62,937 - $86,964	286 New	286 $85,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.